Author :   Titorenko I.B.

Experience of the treatment of NK-/T-cell lymphomas with SMILE regimens. Clinical case
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. Т. 11, № 1-2 (41-42)
Modern approaches to the treatment of the extranodal NK/T-cell lymphoma
Authors: Kryachok I. Aleksyk O.M. Titorenko I.B. Filonenko K.S. T. 10, № 1-2 (37-38)
Hair cell leukemia: a literature review and a clinical case
Authors: Kryachok I. Titorenko I.B. Т. 9, № 3 (35) 2019
The role of PET in patients with relapsе and refractory of Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. Т. 8, № 4 (32) 2018
Quality of life level in patients with diffuse large B-cell lymphoma from high-risk group treated with R-DA-EPOCH regimen
Authors: Filonenko K.S. Kryachok I. Stepanishyna Y.A. Martynchyk A.V.... №4(28) 2017
Brentuхіmab vedotin in the treatment of Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. №2(26) 2017
MALT-lymphoma: etiology, pathogenesis, classification, clinical issues
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №1(25) 2017
Survival comparison of patients with germinal and non-germinal center diffuse large B-cell lymphoma defined by Hans, Colomo and Muris immunohistochemistry algorithms. National Cancer Institute experience
Authors: Kryachok I. Martynchyk A.V. Filonenko K.S. Grabovyi A.N.... №1(25) 2017
Toxic hepatitis in patients with lymphoproliferative diseases
Authors: Kryachok I. Pastushenko J. Martynchyk A.V. Titorenko I.B. №4(24) 2016
Treatment of HIV-related non-Hodgkin’s lymphomas in the era of highly active antiretroviral therapy
Authors: Kryachok I. Skripets Т.V. Ulianchenko K.O. Titorenko I.B.... №3(23) 2016
Lymphoma and hepatitis C
Authors: Kryachok I. Ulianchenko K.O. Kadnikova T. Titorenko I.B.... №3(23) 2016
Primary mediastinal large B-cell lymphoma. The role of positron emission tomography
Authors: Stepanishyna Y.A. Kryachok I. Titorenko I.B. Filonenko Е.... №3(23) 2016
Palliative chemotherapy in patients with refractory and relapsed non-Hodgkin’s lymphomas and Hodgkin’s lymphoma
Authors: Kryachok I. Titorenko I.B. Kadnikova T. Pastushenko J.... №2(22) 2016
Granulocyte colony stimulating factor use during anticancer therapy
Authors: Kryachok I. Titorenko I.B. №3(19) 2015
Results of a multicenter randomized study on the efficacy and toxicity of therapy in patients with Hodgkin’s lymphoma of intermediate-risk group
Authors: Amdiyev A.A. Kryachok I. Titorenko I.B. Kadnikova T.... №3(19) 2015

12